[15] Oral presentation

[O-01] PHASE II CLINICAL TRIAL OF THE ADDITION OF DENDRITIC CELL VACCINES TO NEOADJUVANT CT IN HER2 –ve BC PATIENTS

*Marta Santisteban¹ (1. Clínica Universidad de Navarra)